Advanced Therapies: London’s Landscape Report 2025
Sector insightsEvidence, trends and practical insight for companies, investors and policymakers
Overview
Drawing from a range of sources, MedCity’s review of London’s advanced therapies landscape highlights the city’s core strengths across academia, clinical research, manufacturing, policy and finance. It shows how a balanced mix of infrastructure, investment, academic excellence and clinical expertise has driven rapid growth and early commercial success for companies operating in this subsector.
Key takeaways
- The clinical trial advantageFind out why London is a global leader for advanced therapy clinical trials and how its research infrastructure benefits innovators.
- The “vein‑to‑vein” journeyDiscover the integrated infrastructure that is accelerating the translation of therapies from the lab to patients.
- Spin‑out successLearn how London’s university spin‑outs are outpacing the rest of the UK in attracting funding and achieving commercial success.
